Walder Wyss advised Helvetia Baloise on its inaugural senior bond issuance following the merger of Helvetia and Baloise, placing three tranches in an aggregate amount of CHF 550 million on the Swiss capital market. The proceeds
Tags :Walder Wyss
Walder Wyss advised Liechtensteinisches Pfandbriefinstitut as issuer, as well as LGT Bank and Liechtensteinische Landesbank as member banks, dealers and managers, in connection with Liechtensteinisches Pfandbriefinstitut’s program and issuance of Liechtensteiner Pfandbriefe issued by
Swiss food biotech startup Cosaic AG has closed a USD 6 million late seed financing round, with Walder Wyss advising on the transaction. The round attracted new investors including dsm-firmenich Ventures and Kickfund, alongside existing backers
Walder Wyss advised Planetary, a Swiss full-stack fermentation company, throughout completion of a USD 28 million (CHF 16 million in equity and CHF 6 million in credit) series A equity financing round. Radikal Capital and Oetker Ventures led
Centiel shares have been admitted to trading on the SIX Swiss Exchange following the completion of a reverse takeover. The transaction involved Centiel’s merger with HT5 AG, a company originating from the former Hochdorf
Walder Wyss — alongside lead counsel Linklaters — advised Amundi Energy Transition on its investment in Youdera Group, a platform developing and operating distributed energy solutions for commercial and industrial clients across Europe. The transaction supports Youdera’
Walder Wyss advised production and distribution company DCM Holding Schweiz in connection with the acquisition of Elite-Film as part of a succession plan. The parties DCM produces and distributes selected films to German and Swiss
Walder Wyss advised the banking syndicate — consisting of Zürcher Kantonalbank as mandated lead arranger, coordinator, agent and lender and Basellandschaftliche Kantonalbank as lender — in connection with a club deal financing for Kantonsspital Aarau. The
Walder Wyss advised Nasdaq-listed CRISPR Therapeutics, as the Switzerland-based biopharmaceutical company issued a USD 600 million aggregate principal amount of convertible senior notes. The convertible senior notes were offered in a private offering to qualified institutional
Walder Wyss advised Xsensio, as the Swiss deep-tech company closed a USD 7 million series A financing round. San Francisco-based venture capital firm WI Harper led the round, with participation from Privilège Ventures, the European
